期刊文献+

雷帕霉素抑制mTOR信号通路对EC9706细胞生长及凋亡的影响 被引量:7

Effects of rapamycin inhibiting mTOR signaling pathway on growth and apoptosis of esophageal squamous cell carcinoma cells
暂未订购
导出
摘要 目的:检测食管鳞状细胞癌组织中哺乳动物雷帕霉素靶蛋白(mTOR)的活性及雷帕霉素(rapa)对食管鳞状细胞癌细胞系EC9706细胞生长及凋亡的影响。方法:采用免疫组织化学SP法检测50例食管鳞状细胞癌组织及15例正常食管组织中mTOR蛋白的表达。分别用不同浓度(20、50和100nmol/L)的rapa处理食管鳞状细胞癌EC9706细胞系,以未处理组作为阴性对照,采用流式细胞术测定细胞周期和凋亡率。结果:食管鳞状细胞癌组织中mTOR蛋白的阳性表达率为64.0%(32/50),高于正常组织的13.3%(2/15)(χ2=11.873,P=0.001)。与对照组比较,rapa可使细胞停滞于G0/G1期(F=102.609,P=0.001),且明显促进细胞凋亡(F=916.882,P=0.001)。结论:mTOR信号通路在食管鳞状细胞癌中被显著激活,rapa能抑制食管鳞状细胞癌细胞生长并诱导细胞凋亡。 Aim:To study the activation of mammalian target of rapamycin(mTOR) signaling pathway in esophageal squamous cell carcinoma (ESCC) and the effects of rapamycin on the cell growth and apoptosis of ESCC cell line EC9706.Methods:The expressions of mTOR in 50 ESCC tissues and 15 normal esophageal tissues were detected by immunohistochemistry. The cell cycle and cell apoptosis were determined by using flow cytometry in EC9706 cells treated with rapamycin at different concentrations (20,50 and 100 nmol/L),and the untreated cells were used as control.Results:The expression rate of mTOR in ESCC tissues was 64.0%(32/50),higher than that in normal esophageal tissues,and there was obvious difference(χ2=11.873,P=0.001).Compared with control groups,the EC9706 cells were restrained in G0/G1 phase by rapamycin (F=102.609,P=0.001);rapamycin induced apoptosis of the EC9706 cells (F=916.88.609,P=0.001).Conclusion:mTOR signaling pathway is activated in the ESCC and rapamycin can inhibit the growth and induce apoptosis of ESCC cells.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2010年第3期356-359,共4页 Journal of Zhengzhou University(Medical Sciences)
基金 国家自然科学基金资助项目30901778 教育部"十.五""211工程"重点学科建设项目教重字2002-2
关键词 食管鳞状细胞癌 哺乳动物雷帕霉素靶蛋白 雷帕霉素 EC9706 esophageal squamous cell carcinoma mammalian target of rapamycin rapamycin EC9706 cells
  • 相关文献

参考文献10

  • 1Jiang BH,Liu LZ. Role of roTOR in anticancer drug resistance: perspectives for improved drug treatment [ J]. Drug Resist Updat, 2008,11 ( 3 ) :63.
  • 2Georgakis GV, Younes A. From Rapa Nui to rapamycin: targeting PI3K/Akt/mTOR for cancer therapy [ J]. Expert Rev Anticancer Ther, 2006, 6( 1 ) :131.
  • 3Shaw RJ, Cantley LC. Ras, PI ( 3 ) K and mTOR signaling controls tumor cell growth [ J ]. Nature, 2006,441 ( 7 092 ) : 424.
  • 4Asano T, Yao Y,Zhu J, et al. The rapamycin anolog CCI-779 is a potent inhibitor of pancreatic cancer cell proliferation[J]. Biochem Biophys Res Commun,2005,331(1): 295.
  • 5Dong M, Nio Y, Sato Y, et al pression in primary invasive Comparative study of p53 exductal carcinoma of the pancreas between Chinese and Japanese [ J ]. Pancreas, 1996 17(3) :229.
  • 6Martin DE, Hall MN. The expanding TOR signaling network[J]. Curr Opin Cell Biol, 2005, 17(2) :158.
  • 7Piguet AC, Semela D, Keogh A, et ah Inhibition of mTOR in combination with doxorubicin in an experimental model of hepatocellular carcinoma [ J ]. J Hepatol, 2008,49 ( 1 ) : 78.
  • 8O'Reilly KE, Rojo F, She QB, et al. mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt[J]. Cancer Res, 2006, 66(3):1 500.
  • 9Chan S,Scheulen ME,Johnston S,et al. Phase II study of temsirolimus (CCI-779) , a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer[ J]. J Clin Oncol,2005,23 (23) :5 314.
  • 10Galanis E, Buckner JC, Maurer M J, et al. Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatmeat Group Stady[ J]. J Clin Oncol, 2005, 23(23) : 5 294.

同被引文献80

  • 1步丽梅,孟祥军,吴恺,徐敏,陆伦根.雷帕霉素对人胰腺癌细胞SW1990的mTOR信号通路的影响[J].现代生物医学进展,2011,11(S2):5013-5016. 被引量:1
  • 2Yong-gang ZHANG,Yu-guang LI,Bao-guo LIU,Rui-hong WEI,Dong-ming WANG,Xue-rui TAN,Ding-fang BU,Yong-zheng PANG,Chao-shu TANG.Urotensin Ⅱ accelerates cardiac fibrosis and hypertrophy of rats induced by isoproterenol[J].Acta Pharmacologica Sinica,2007,28(1):36-43. 被引量:36
  • 3侯桂琴,范天黎,鲁照明,刘兰琦,许培荣,薛乐勋,王建人.EC9706和Eca109细胞中雷帕霉素靶蛋白信号通路激活状态观察[J].郑州大学学报(医学版),2007,42(2):223-225. 被引量:11
  • 4付晓春,王希,郑辉,马丽萍.竹叶总黄酮抗大鼠心肌细胞凋亡作用的研究[J].中西医结合心脑血管病杂志,2007,5(2):125-126. 被引量:8
  • 5Jiang BH, Liu LZ. Role of mTOR in anticancer drug resistance:perspectives for improved drug treatment[J]. Drug Resist Updat,2008,11(3) :63 76.
  • 6Murakami D,Tsujitani S,Osaki T, et al. Expression of phosphorylated Akt(pAkt) in gastric carcinoma predicts prognosis and efficacy of chemotherapy[J]. Gastric Cancer,2007,10( 1 ) : 45-51.
  • 7Baldo P, Cecco S, Giacomin E, et al. mTOR pathway and mTOR inhibitors as agents for cancer therapy[J]. Cnrr Cancer Drug Targets,2008,8 (8) : 647-665.
  • 8Kapoor A,Figlin RA. Targeted inhibition of mammalian target of rapamycin for the treatment of advanced renal cell carcinoma[J]. Cancer,2009,115(16) :3618-3630.
  • 9Boffa DJ, Luan 1v, Thomas D, et al. Rapamyein Inhibits the Growth and Metastatic Progression of Non-Small Cell Lung Caneer[J]. Clin Cancer Res,2004,10(1 Pt 1 ) :293-300.
  • 10Hipp S, Ringshausen I, Oelsner M, et al. Inhibition of the mammalian target of rapamycin and the induction of cell cycle ar-rest in mantle cell lymphoma cells[J]. Haematologica,2005,911 (10):1433-1434.

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部